Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SAA4 |
| Upstream (Parents) |
|---|
| (<<) ORM1 → SAA4 |
| Downstream (Children) |
|---|
| SAA4 → ACAT2 (>>) |
| SAA4 → ACTG1 (>>) |
| SAA4 → AIFM1 (>>) |
| SAA4 → ALDOA (>>) |
| SAA4 → AQP3 (>>) |
| SAA4 → BDH1 (>>) |
| SAA4 → CBS (>>) |
| SAA4 → CTSF (>>) |
| SAA4 → CXCL2 (>>) |
| SAA4 → CYP1A2 (>>) |
| SAA4 → CYP4F2 (>>) |
| SAA4 → DDX21 (>>) |
| SAA4 → EGFR (>>) |
| SAA4 → FNDC4 (>>) |
| SAA4 → GNE (>>) |
| SAA4 → GOT1 (>>) |
| SAA4 → GPX3 (>>) |
| SAA4 → HSD11B1 (>>) |
| SAA4 → HSD17B2 (>>) |
| SAA4 → HYAL1 (>>) |
| SAA4 → ITGA2 (>>) |
| SAA4 → KLF11 (>>) |
| SAA4 → LRP6 (>>) |
| SAA4 → MAFF (>>) |
| SAA4 → MAP3K4 (>>) |
| SAA4 → MT1F (>>) |
| SAA4 → MT1G (>>) |
| SAA4 → MT1P2 (>>) |
| SAA4 → NLGN4Y (>>) |
| SAA4 → NNMT (>>) |
| SAA4 → PHGDH (>>) |
| SAA4 → PKM2 (>>) |
| SAA4 → PNPLA3 (>>) |
| SAA4 → PRDX6 (>>) |
| SAA4 → PRKCD (>>) |
| SAA4 → PTGER4 (>>) |
| SAA4 → RASA1 (>>) |
| SAA4 → RBKS (>>) |
| SAA4 → RDH16 (>>) |
| SAA4 → RHOD (>>) |
| SAA4 → RNASE4 (>>) |
| SAA4 → RORA (>>) |
| SAA4 → SMO (>>) |
| SAA4 → ST3GAL1 (>>) |
| SAA4 → ST3GAL6 (>>) |
| SAA4 → TFPI2 (>>) |
| SAA4 → TRIM32 (>>) |
